| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |